Veterinary Medicines Information website

Receptal 4 microgram/ml solution for injection

Authorised
  • Buserelin
Download as PDF

Product identification

Medicine name:
Receptal 4 microgram/ml solution for injection
Active substance:
  • Buserelin
Target species:
  • Cattle
  • Horse
  • Rabbit
  • Pig
  • Trout
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Buserelin
    4.00
    microgram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        0
        day
    • Rabbit
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Trout
      • Meat and offal
        0
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        0
        day
    • Rabbit
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        0
        day
    • Rabbit
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH01CA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Colourless type I glass vial of 2.5 ml, closed with an laminated, halogenated butyl rubber stopper and an aluminium cap.Pack sizes:Cardboard box with 10 vials of 2.5 ml.
  • Colourless type I glass vial of 5 ml, closed with an laminated, halogenated butyl rubber stopper and an aluminium cap.Pack sizes:Cardboard box with 10 vials of 5 ml.
  • Colourless type I glass vial of 10 ml, closed with a halogenated butyl rubber stopper and an aluminium cap.Pack sizes:Cardboard box with 10 vials of 10 ml.
  • Colourless type II glass vial of 50 ml, closed with a halogenated butyl rubber stopper and an aluminium cap.Pack sizes:Cardboard box with 10 vials of 50 ml.
  • Colourless type II glass vial of 50 ml, closed with a halogenated butyl rubber stopper and an aluminium cap.Pack sizes:Cardboard box with 5 vials of 50 ml.
  • Colourless type I glass vial of 10 ml, closed with a halogenated butyl rubber stopper and an aluminium cap.Pack sizes:Cardboard box with 5 vials of 10 ml.
  • Colourless type I glass vial of 5 ml, closed with a laminated, halogenated butyl rubber stopper and an aluminium cap.Pack sizes:Cardboard box with 5 vials of 5 ml.
  • Colourless type I glass vial of 2.5 ml, closed with an laminated, halogenated butyl rubber stopper and an aluminium cap.Pack sizes:Cardboard box with 5 vials of 2.5 ml.
  • Colourless type II glass vial of 50 ml, closed with a halogenated butyl rubber stopper and an aluminium cap.Pack size:Cardboard box with 1 vial of 50 ml.
  • Colourless type I glass vial of 10 ml, closed with a halogenated butyl rubber stopper and an aluminium cap.Pack size:Cardboard box with 1 vial of 10 ml.
  • Colourless type I glass vial of 5 ml, closed with an laminated, halogenated butyl rubber stopper and an aluminium cap.Pack size:Cardboard box with 1 vial of 5 ml.
  • Colourless type I glass vial of 2.5 ml, closed with a laminated, halogenated butyl rubber stopper and an aluminium cap.Pack sizes:Cardboard box with 1 vial of 2.5 ml.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International GmbH
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10996/123/001
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0679/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 21/06/2026
Download

Combined File of all Documents

English (PDF)
Published on: 21/06/2026
Download